Comparison of adjuvant therapy with tamoxifen and goserelin vs. CMF in premenopausal stage I and II hormone-responsive breast cancer patients: four-year results of Austrian Breast Cancer Study Group (ABCSG) trial 5
暂无分享,去创建一个
M. Gnant | H. Samonigg | R. Jakesz | E. Kubista | G. Steger | H. Hausmaninger | M. Fridrik | D. Depisch | M. Stierer | G. Jatzko | F. Hofbauer | P. Steindorfer | G. Reiner | R. Kolb